跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40 条关于
“Numab”
全部
40
临床试验
10
药物
18
机构
2
资讯
10
去年
Physiomics Secures New Contract with Numab Therapeutics for Inflammation Study
去年
J&J Acquires Atopic Dermatitis Drug NM26 in $1.25 Billion Deal with Numab Therapeutics
2年前
Johnson & Johnson to Acquire Yellow Jersey Therapeutics for $1.25 Billion, Bolstering Atopic Dermatitis Pipeline
2个月前
Physiomics Director Ian Bagnall Increases Stake with £5,000 Share Purchase
9个月前
Physiomics Expands Biometrics Services with GARDP Partnership for Antibiotic Trial Optimization
去年
Physiomics' PREDICT-ONC Trial Receives Approval to Optimize Chemotherapy Dosing
去年
Tetraspecific Antibodies Poised for First FDA Approval by 2029, Market Report Reveals
去年
UK Digital Health Platform Numan Raises $60M to Expand Into Women's Health
去年
Singapore's PRL3-zumab Shows Promise in Phase II Trial for Treatment-Resistant Solid Tumors
去年
Singapore-Developed Cancer Drug PRL3-zumab Shows Promise for Treating Vision Loss in AMD and Diabetic Retinopathy